Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+9.13%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$100B
AUM Growth
-$15.7B
Cap. Flow
-$22.5B
Cap. Flow %
-22.43%
Top 10 Hldgs %
15.09%
Holding
3,879
New
490
Increased
1,156
Reduced
1,673
Closed
545

Sector Composition

1 Healthcare 22.93%
2 Technology 16.66%
3 Consumer Staples 12.21%
4 Consumer Discretionary 9.52%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GOL
3426
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-452,200
Closed -$3.07M
NETI
3427
DELISTED
Eneti Inc.
NETI
-32,289
Closed -$494K
CYTO
3428
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
-143
Closed -$54K
RAD
3429
DELISTED
Rite Aid Corporation
RAD
-738,490
Closed -$12.6M
RETA
3430
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-134,700
Closed -$21M
BLU
3431
DELISTED
BELLUS Health Inc.
BLU
-65,438
Closed -$677K
CYAD
3432
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
-10,300
Closed -$110K
DTEA
3433
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
-129,549
Closed -$124K
AGRX
3434
DELISTED
Agile Therapeutics, Inc
AGRX
-72
Closed -$401K
OBSV
3435
DELISTED
ObsEva SA Ordinary Shares
OBSV
-221,500
Closed -$1.31M
TMDI
3436
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
-34,645
Closed -$29K
TCDA
3437
DELISTED
Tricida, Inc. Common Stock
TCDA
-160,717
Closed -$4.42M
ZEN
3438
DELISTED
ZENDESK INC
ZEN
-6,000
Closed -$531K
PHAS
3439
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-131,500
Closed -$605K
USWS
3440
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
-1,615
Closed -$17K
CCXI
3441
DELISTED
ChemoCentryx, Inc.
CCXI
-265,100
Closed -$15.3M
GBT
3442
DELISTED
Global Blood Therapeutics, Inc.
GBT
-50,400
Closed -$3.18M
TYME
3443
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
-186,531
Closed -$248K
ALNA
3444
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
-617,270
Closed -$975K
ATHX
3445
DELISTED
Athersys, Inc. Common Stock
ATHX
-752
Closed -$52K
ACC
3446
DELISTED
American Campus Communities, Inc.
ACC
-255,628
Closed -$8.94M
CERN
3447
DELISTED
Cerner Corp
CERN
-395,404
Closed -$27.1M
ESBK
3448
DELISTED
Elmira Savings Bank Elmira NY
ESBK
-10,068
Closed -$111K
EVFM
3449
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-18,574
Closed -$788K
LEVL
3450
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
-12,300
Closed -$206K